Literature DB >> 23869537

TGF-β2, a protective intestinal cytokine, is abundant in maternal human milk and human-derived fortifiers but not in donor human milk.

Aaron A Reeves1, Marney C Johnson, Margarita M Vasquez, Akhil Maheshwari, Cynthia L Blanco.   

Abstract

OBJECTIVE: This study compared cytokines (in particular transforming growth factor [TGF]-β2) and lactoferrin in maternal human milk (MHM), human-derived milk fortifier (HDMF), and donor human milk (DHM).
MATERIALS AND METHODS: MHM was randomly collected from breastfeeding mothers who had no infectious illness at the time of milk expression. HDMF and DHM were products derived from human milk processed by Holder pasteurization. MHM samples were collected at different times (early/late) and gestations (preterm/term). Lactoferrin was analyzed by western blotting, and cytokines were quantified using commercial enzyme-linked immunosorbent assays. Significance was determined using analysis of variance.
RESULTS: In the 164 samples analyzed, TGF-β2 concentrations in HDMF and preterm MHM (at all collection times) were fivefold higher than in DHM (p<0.05). Early preterm MHM had levels of interleukin (IL)-10 and IL-18, 11-fold higher than DHM (p<0.05). IL-6 in DHM was 0.3% of the content found in MHM. IL-18 was fourfold higher in early MHM versus late MHM regardless of gestational age (p<0.05). Lactoferrin concentration in DHM was 6% of that found in MHM.
CONCLUSIONS: Pasteurization decreases concentrations of most cytokines and lactoferrin in DHM. TGF-β2, a protective intestinal cytokine, has comparable concentrations in HDMF to MHM despite pasteurization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23869537      PMCID: PMC3919475          DOI: 10.1089/bfm.2013.0017

Source DB:  PubMed          Journal:  Breastfeed Med        ISSN: 1556-8253            Impact factor:   1.817


  28 in total

Review 1.  Enteral nutrition in adult Crohn's disease: present status and perspectives.

Authors:  Benoît Dupont; Claire Dupont; Anne-Marie Justum; Marie-Astrid Piquet; Jean-Marie Reimund
Journal:  Mol Nutr Food Res       Date:  2008-08       Impact factor: 5.914

Review 2.  Control of systemic and local inflammation with transforming growth factor beta containing formulas.

Authors:  John M E Fell
Journal:  JPEN J Parenter Enteral Nutr       Date:  2005 Jul-Aug       Impact factor: 4.016

3.  Randomized trial of donor human milk versus preterm formula as substitutes for mothers' own milk in the feeding of extremely premature infants.

Authors:  Richard J Schanler; Chantal Lau; Nancy M Hurst; Elliot O'Brian Smith
Journal:  Pediatrics       Date:  2005-08       Impact factor: 7.124

4.  Decreased development of necrotizing enterocolitis in IL-18-deficient mice.

Authors:  Melissa D Halpern; Ludmila Khailova; Dania Molla-Hosseini; Kelly Arganbright; Charity Reynolds; Masako Yajima; Junji Hoshiba; Bohuslav Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-10-18       Impact factor: 4.052

5.  Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation.

Authors:  Vittoria Buccigrossi; Giulio de Marco; Eugenia Bruzzese; Luigi Ombrato; Ileana Bracale; Gaetano Polito; Alfredo Guarino
Journal:  Pediatr Res       Date:  2007-04       Impact factor: 3.756

6.  Heat susceptibility of interleukin-10 and other cytokines in donor human milk.

Authors:  Peter B Untalan; Susan E Keeney; Kimberly H Palkowetz; Audelio Rivera; Armond S Goldman
Journal:  Breastfeed Med       Date:  2009-09       Impact factor: 1.817

7.  Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis.

Authors:  Mohan Pammi Venkatesh; Liang Rong
Journal:  J Med Microbiol       Date:  2008-09       Impact factor: 2.472

8.  Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial.

Authors:  Paolo Manzoni; Matteo Rinaldi; Silvia Cattani; Lorenza Pugni; Mario Giovanni Romeo; Hubert Messner; Ilaria Stolfi; Lidia Decembrino; Nicola Laforgia; Federica Vagnarelli; Luigi Memo; Linda Bordignon; Onofrio Sergio Saia; Milena Maule; Elena Gallo; Michael Mostert; Cristiana Magnani; Michele Quercia; Lina Bollani; Roberto Pedicino; Livia Renzullo; Pasqua Betta; Fabio Mosca; Fabrizio Ferrari; Rosario Magaldi; Mauro Stronati; Daniele Farina
Journal:  JAMA       Date:  2009-10-07       Impact factor: 56.272

9.  Nutritional supplementation with polymeric diet enriched with transforming growth factor-beta 2 for children with Crohn's disease.

Authors:  Corina Hartman; Drora Berkowitz; Batia Weiss; Ron Shaoul; Arie Levine; Orly Eshach Adiv; Riki Shapira; Akiva Fradkin; Michael Wilschanski; Ada Tamir; Raanan Shamir
Journal:  Isr Med Assoc J       Date:  2008-07       Impact factor: 0.892

10.  An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products.

Authors:  Sandra Sullivan; Richard J Schanler; Jae H Kim; Aloka L Patel; Rudolf Trawöger; Ursula Kiechl-Kohlendorfer; Gary M Chan; Cynthia L Blanco; Steven Abrams; C Michael Cotten; Nirupama Laroia; Richard A Ehrenkranz; Golde Dudell; Elizabeth A Cristofalo; Paula Meier; Martin L Lee; David J Rechtman; Alan Lucas
Journal:  J Pediatr       Date:  2009-12-29       Impact factor: 4.406

View more
  9 in total

1.  Transforming growth factor-β2 is sequestered in preterm human milk by chondroitin sulfate proteoglycans.

Authors:  Kopperuncholan Namachivayam; Hayley P Coffing; Nehru Viji Sankaranarayanan; Yingzi Jin; Krishnan MohanKumar; Brandy L Frost; Cynthia L Blanco; Aloka L Patel; Paula P Meier; Steven A Garzon; Umesh R Desai; Akhil Maheshwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-06-04       Impact factor: 4.052

2.  Systematic Review of the Effect of Enteral Feeding on Gut Microbiota in Preterm Infants.

Authors:  Wanli Xu; Michelle P Judge; Kendra Maas; Naveed Hussain; Jacqueline M McGrath; Wendy A Henderson; Xiaomei Cong
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2017-10-14

3.  Influence of Feeding Type on Gut Microbiome Development in Hospitalized Preterm Infants.

Authors:  Xiaomei Cong; Michelle Judge; Wanli Xu; Ana Diallo; Susan Janton; Elizabeth A Brownell; Kendra Maas; Joerg Graf
Journal:  Nurs Res       Date:  2017 Mar/Apr       Impact factor: 2.381

Review 4.  Clinical applications of bioactive milk components.

Authors:  David R Hill; David S Newburg
Journal:  Nutr Rev       Date:  2015-07       Impact factor: 7.110

5.  Cytokines, Chemokines, and Growth Factors in Banked Human Donor Milk for Preterm Infants.

Authors:  Maureen Groer; Allyson Duffy; Shannon Morse; Bradley Kane; Judy Zaritt; Shari Roberts; Terri Ashmeade
Journal:  J Hum Lact       Date:  2014-03-24       Impact factor: 2.219

Review 6.  Inherited nongenetic influences on the gut microbiome and immune system.

Authors:  Kathryn A Knoop; Lori R Holtz; Rodney D Newberry
Journal:  Birth Defects Res       Date:  2018-12-01       Impact factor: 2.344

7.  The effect of postpartum vitamin A supplementation on breast milk immune regulators and infant immune functions: study protocol of a randomized, controlled trial.

Authors:  Shaikh Meshbahuddin Ahmad; Md Iqbal Hossain; Peter Bergman; Yearul Kabir; Rubhana Raqib
Journal:  Trials       Date:  2015-03-31       Impact factor: 2.279

8.  Effect of HTST and Holder Pasteurization on the Concentration of Immunoglobulins, Growth Factors, and Hormones in Donor Human Milk.

Authors:  Diana Escuder-Vieco; Irene Espinosa-Martos; Juan M Rodríguez; Leónides Fernández; Carmen Rosa Pallás-Alonso
Journal:  Front Immunol       Date:  2018-09-27       Impact factor: 7.561

9.  All-Trans Retinoic Acid Induces TGF-β2 in Intestinal Epithelial Cells via RhoA- and p38α MAPK-Mediated Activation of the Transcription Factor ATF2.

Authors:  Kopperuncholan Namachivayam; Krishnan MohanKumar; Dima Arbach; Ramasamy Jagadeeswaran; Sunil K Jain; Viswanathan Natarajan; Dolly Mehta; Robert P Jankov; Akhil Maheshwari
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.